Published in Women's Health Weekly, August 5th, 2004
"Mild hyperhomocysteinemia is a risk factor for both ischemic heart disease and venous thromboembolism. The effects of transdermal estrogen replacement therapy (ERT) on homocysteine metabolism in postmenopausal women have scarcely been investigated," the researchers said.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly